Ligand Pharmaceuticals (LGND) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
1.21
1.84
2.46
3.09

Details

Expected EPS
1.815714
Actual EPS
1.63
Surprise EPS
-0.19
Surprise Percent
-10.23%

Description

⁨Ligand Pharmaceuticals⁩ (⁦LGND⁩) has reported earnings of ⁦1.63⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts